{"id":"NCT02347774","sponsor":"Sunovion Respiratory Development Inc.","briefTitle":"Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD (GOLDEN-4)","officialTitle":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Trial of 12 Weeks of Treatment With Nebulized SUN-101 in Patients With COPD: GOLDEN-4 (Glycopyrrolate for Obstructive Lung Disease Via Electronic Nebulizer","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-02","primaryCompletion":"2015-12","completion":"2015-12","firstPosted":"2015-01-27","resultsPosted":"2018-03-13","lastUpdate":"2018-03-13"},"enrollment":641,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["COPD","Chronic Obstructive Pulmonary Disease"],"interventions":[{"type":"DRUG","name":"SUN-101 50 mcg BID eFlow (CS) nebulizer","otherNames":[]},{"type":"DRUG","name":"SUN-101 25 mcg BID eFlow (CS) nebulizer","otherNames":[]},{"type":"DRUG","name":"Placebo eFlow (CS) nebulizer","otherNames":[]}],"arms":[{"label":"SUN-101 50 mcg BID eFlow (CS) nebulizer","type":"EXPERIMENTAL"},{"label":"SUN-101 25 mcg BID e-Flow (CS) nebulizer","type":"EXPERIMENTAL"},{"label":"Placebo BID Eflow (CS) nebulizer","type":"PLACEBO_COMPARATOR"}],"summary":"This is a trial of 12 weeks of treatment with nebulized SUN-101 using an Investigational eFlowÂ® Closed System (CS) nebulizer in subjects with chronic obstructive pulmonary disease (COPD) according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD 2014) guidelines.","primaryOutcome":{"measure":"Change From Baseline in Trough Forced Expiratory Volume in 1 Second (FEV1) at Week 12","timeFrame":"baseline and Week 12","effectByArm":[{"arm":"SUN-101 50 mcg BID eFlow (CS) Nebulizer","deltaMin":0.0847,"sd":0.01423},{"arm":"SUN-101 25 mcg BID e-Flow (CS) Nebulizer","deltaMin":0.0921,"sd":0.01446},{"arm":"Placebo BID Eflow (CS) Nebulizer","deltaMin":0.0111,"sd":0.01452}],"pValues":[{"comp":"OG000 vs OG002","p":"0.0002"},{"comp":"OG001 vs OG002","p":"0.0001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":45,"countries":["United States"]},"refs":{"pmids":["28838685","30587959","30584583"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":214},"commonTop":["chronic obstructive pulmonary disease","cough","dyspnoea"]}}